Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedMar 29, 2026
DataAggregated Company Financials
Companies114
  • 7D-8.6%
  • 3M-18.9%
  • 1Y-20.6%
  • YTD-18.9%

Over the last 7 days, the Personal Products industry has dropped 8.6%, driven by a pullback from Estée Lauder Companies of 22%. In contrast, Olaplex Holdings has gained 52%. Overall the industry is down 21% in 12 months. As for the next few years, earnings are expected to grow by 29% per annum.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 29 Mar 2026US$73.8bUS$48.2bUS$652.7m21.3x113x1.5x
Tue, 24 Feb 2026US$97.3bUS$48.1bUS$858.3m22.8x113.4x2x
Thu, 22 Jan 2026US$94.8bUS$47.6bUS$350.1m23.2x270.6x2x
Sat, 20 Dec 2025US$90.8bUS$47.6bUS$351.6m22.8x258.4x1.9x
Mon, 17 Nov 2025US$82.7bUS$47.5bUS$552.2m21.5x149.8x1.7x
Wed, 15 Oct 2025US$89.8bUS$47.7bUS$308.0m20.3x291.7x1.9x
Fri, 12 Sep 2025US$94.8bUS$47.6bUS$304.0m21.5x311.8x2x
Sun, 10 Aug 2025US$98.8bUS$48.1bUS$562.3m19.4x175.7x2.1x
Tue, 08 Jul 2025US$101.5bUS$48.0bUS$109.5m18.7x926.8x2.1x
Thu, 05 Jun 2025US$95.4bUS$48.0bUS$127.2m17.5x750.2x2x
Sat, 03 May 2025US$90.2bUS$48.3bUS$374.3m21.2x241.1x1.9x
Mon, 31 Mar 2025US$91.1bUS$48.7bUS$552.2m23.6x165x1.9x
Wed, 26 Feb 2025US$96.4bUS$48.9bUS$328.4m27.6x293.5x2x
Fri, 24 Jan 2025US$97.7bUS$49.3bUS$1.5b24.8x66.3x2x
Sun, 22 Dec 2024US$98.4bUS$49.3bUS$1.5b27.2x66.7x2x
Tue, 19 Nov 2024US$98.0bUS$49.3bUS$1.5b26.6x66.8x2x
Thu, 17 Oct 2024US$104.4bUS$49.5bUS$1.6b26.7x64.5x2.1x
Sat, 14 Sep 2024US$106.2bUS$49.5bUS$1.6b21.6x64.8x2.1x
Mon, 12 Aug 2024US$106.7bUS$49.2bUS$1.8b23.1x57.8x2.2x
Wed, 10 Jul 2024US$111.4bUS$49.0bUS$2.4b21.1x46x2.3x
Fri, 07 Jun 2024US$115.8bUS$49.0bUS$2.4b22.7x47.8x2.4x
Sun, 05 May 2024US$120.0bUS$48.7bUS$2.7b24x44.7x2.5x
Tue, 02 Apr 2024US$136.6bUS$48.8bUS$2.5b26.9x54.1x2.8x
Thu, 29 Feb 2024US$130.5bUS$49.0bUS$2.5b30.4x52.7x2.7x
Sat, 27 Jan 2024US$123.5bUS$50.1bUS$2.6b27.1x48.4x2.5x
Mon, 25 Dec 2023US$128.8bUS$49.9bUS$2.6b24.6x48.9x2.6x
Wed, 22 Nov 2023US$113.1bUS$50.0bUS$2.6b21.9x43.8x2.3x
Fri, 20 Oct 2023US$117.1bUS$50.0bUS$3.3b23x35.8x2.3x
Sun, 17 Sep 2023US$130.4bUS$50.0bUS$3.3b20.5x39.7x2.6x
Tue, 15 Aug 2023US$139.2bUS$49.8bUS$3.1b20.4x45.5x2.8x
Thu, 13 Jul 2023US$150.4bUS$49.3bUS$3.1b22.6x48x3.1x
Sat, 10 Jun 2023US$144.1bUS$49.3bUS$3.1b22.2x46x2.9x
Mon, 08 May 2023US$155.6bUS$48.8bUS$3.3b21x46.7x3.2x
Wed, 05 Apr 2023US$120.8bUS$34.6bUS$1.6b18.3x75.8x3.5x
Price to Earnings Ratio

75.8x


Total Market Cap: US$120.8bTotal Earnings: US$1.6bTotal Revenue: US$34.6bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 167.7x202420252026
Current Industry PE
  • Investors are pessimistic on the American Personal Products industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 113x which is lower than its 3-year average PE of 168x.
  • The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 26% per year over the last three years.
  • Meanwhile revenues for these companies have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market-1.89%
Consumer Staples1.68%
Personal Products-8.57%
Personal Products-8.57%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
OLPX Olaplex HoldingsUS$2.0251.9%
+US$466.6m		53.0%PS3.2x
KVUE KenvueUS$17.520.7%
+US$230.0m		-26.1%PE22.8x
EPC Edgewell Personal CareUS$21.028.2%
+US$74.3m		-31.4%PE155.9x
HNST Honest CompanyUS$2.887.9%
+US$23.6m		-39.2%PS0.9x
IPAR InterparfumsUS$90.530.6%
+US$18.3m		-22.8%PE17.2x

Latest News

ELF
US$61.05
e.l.f. Beauty
7D
-15.8%
1Y
-5.8%
KVUE
US$17.52
Kenvue
7D
0.7%
1Y
-26.1%
IPAR
US$90.53
Interparfums
7D
0.6%
1Y
-22.8%

IPAR: Asset Light Model Will Benefit From New Long Term Fragrance Licenses

Analysts lifted their price target on Interparfums to $111.20 per share, supported by updated assumptions for a slightly lower discount rate, consistent revenue growth of 6.12%, stable profit margin of 11.19%, and a refined future P/E of 21.28x. Analyst Commentary Bullish Takeaways Bullish analysts see the refined future P/E of 21.28x as consistent with the company’s earnings profile, given the working assumptions around revenue growth and margins, rather than stretched for the sector.
SKIN
US$0.81
Beauty Health
7D
-28.7%
1Y
-39.0%
OLPX
US$2.02
Olaplex Holdings
7D
51.9%
1Y
53.0%
COTY
US$2.00
Coty
7D
-6.5%
1Y
-63.3%
EL
US$67.23
Estée Lauder Companies
7D
-21.8%
1Y
2.8%
AXIL
US$7.23
AXIL Brands
7D
23.8%
1Y
33.5%
NAGE
US$4.20
Niagen Bioscience
7D
-9.9%
1Y
-38.0%

NAGE: Core Demand And Injectables Will Support Future Upside Potential

Analysts have trimmed their price target on Niagen Bioscience to $13 from $14. This reflects updated models after Q4 results that pointed to steady demand in the core business and potential upside from the injectable segment.
HLF
US$14.41
Herbalife
7D
-2.0%
1Y
68.1%

HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures

Herbalife's analyst price target has shifted toward $9.00, with recent research citing Q4 results viewed as solid by some firms, new 2026 guidance, and mixed views on valuation and competitive pressures. Some analysts also commented that regulatory concerns in the U.S. are considered resolved and the business model more sustainable.
HNST
US$2.88
Honest Company
7D
7.9%
1Y
-39.2%

HNST: Consistent Execution And Buyback Program Will Shape Transformation 2.0 Outlook

Analysts have trimmed Honest Company's average price target by about $1 to align with revised firm targets of $5 and $3.50, citing slightly soft Q4 results, the need for several quarters of consistent execution, and a longer timeline before the business outlook becomes clearer. Analyst Commentary Bearish analysts are resetting expectations on Honest Company, trimming price targets and flagging a longer wait before the story becomes clearer.
BRBR
US$15.35
BellRing Brands
7D
-10.9%
1Y
-79.3%

BRBR: Protein Adoption And Reset Expectations Will Shape Future Upside Potential

BellRing Brands' fair value estimate has shifted from $50.00 to $35.00 as analysts recalibrate price targets across the group, citing softer recent volume data, a reset in assumed future P/E multiples, and a more measured stance on competition, even as they still point to growing mainstream demand for convenient protein shakes and snacks. Analyst Commentary Recent Street research on BellRing Brands points to a mixed but still constructive backdrop, with several bullish analysts highlighting the broader protein theme and the company's role in it, even as price targets reset lower.
YSG
US$2.89
Yatsen Holding
7D
-24.1%
1Y
-42.2%

YSG: Convertible Notes And Revenue Outlook Will Support Earnings Recovery

Analysts have lifted their price target on Yatsen Holding from $7.14 to $7.54, reflecting updated assumptions around fair value, discount rate, revenue growth, profit margin, and forward P/E that they see as better aligning the stock with its current risk and earnings profile. What's in the News Yatsen Holding plans a private placement of Senior Convertible Notes totaling US$120,000,000, paired with warrants to purchase Class A ordinary shares, under a purchase agreement dated March 11, 2026 (Key Developments).
EPC
US$21.02
Edgewell Personal Care
7D
8.2%
1Y
-31.4%

EPC: Share Repurchases And Margin Expansion Will Support Attractive Returns Through 2026

Analysts have raised the implied fair value for Edgewell Personal Care from about $23.86 to $24.33. This reflects updated views that balance softer revenue growth expectations with higher projected profit margins and a lower discount rate, alongside a modestly lower future P/E assumption.
CABR
US$1.24
Caring Brands
7D
18.1%
1Y
n/a
FTLF
US$14.28
FitLife Brands
7D
12.5%
1Y
13.2%

Some Confidence Is Lacking In FitLife Brands, Inc.'s (NASDAQ:FTLF) P/E

Dec 16
Some Confidence Is Lacking In FitLife Brands, Inc.'s (NASDAQ:FTLF) P/E